Other
Common stock, shares issued (in shares)
Alnylam Pharmaceuticals Common stock, shares issued (in shares) increased by 0.8% to $133.44M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.4%, from $130.31M to $133.44M. Over 5 years (FY 2020 to FY 2025), Common stock, shares issued (in shares) shows an upward trend with a 2.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ3 2024
Last reportedQ3 2025
How to read this metric
An increase indicates equity issuance, while a decrease (rare) would indicate share cancellations.
Detailed definition
The total number of shares that have been sold or distributed to shareholders since the company's inception. This includ...
Peer comparison
Standard corporate governance metric; comparable to 'Issued Shares' at any public company.
Metric ID:
other_common_stock_shares_issuedHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $118.60M | $119.48M | $120.18M | $120.73M | $120.99M | $122.99M | $123.93M | $124.24M | $124.90M | $125.45M | $125.79M | $126.46M | $128.02M | $128.84M | $129.29M | $130.31M | $130.98M | $131.79M | $132.38M | $133.44M |
| QoQ Change | — | +0.7% | +0.6% | +0.5% | +0.2% | +1.7% | +0.8% | +0.3% | +0.5% | +0.4% | +0.3% | +0.5% | +1.2% | +0.6% | +0.4% | +0.8% | +0.5% | +0.6% | +0.4% | +0.8% |
| YoY Change | — | — | — | — | +2.0% | +2.9% | +3.1% | +2.9% | +3.2% | +2.0% | +1.5% | +1.8% | +2.5% | +2.7% | +2.8% | +3.0% | +2.3% | +2.3% | +2.4% | +2.4% |
Range$118.60M – $133.44M
CAGR+2.5%
Avg YoY Growth+2.5%
Median YoY Growth+2.5%
Current Streak19+ quarters growth
Common stock, shares issued (in shares) at Other Companies
Frequently Asked Questions
- What is Alnylam Pharmaceuticals's common stock, shares issued (in shares)?
- Alnylam Pharmaceuticals (ALNY) reported common stock, shares issued (in shares) of $133.44M in Q1 2026.
- How has Alnylam Pharmaceuticals's common stock, shares issued (in shares) changed year-over-year?
- Alnylam Pharmaceuticals's common stock, shares issued (in shares) increased by 2.4% year-over-year, from $130.31M to $133.44M.
- What is the long-term trend for Alnylam Pharmaceuticals's common stock, shares issued (in shares)?
- Over 5 years (2020 to 2025), Alnylam Pharmaceuticals's common stock, shares issued (in shares) has grown at a 2.6% compound annual growth rate (CAGR), from $116.43M to $132.38M.
- What does common stock, shares issued (in shares) mean?
- The total number of shares the company has ever created and distributed.